ADVANCE CONTRACT AWARD NOTICE (ACAN)
Title: Expert membership for the Non-Insured Health Benefits (NIHB) Drugs and Therapeutics
Advisory Committee (DTAC)
Solicitation Number: 1000204823 and 1000204842
1. The Purpose and Explanation of an ACAN
An Advance Contract Award Notice (ACAN) allows The Department of Indigenous Services Canada to post a notice for no less than fifteen (15) calendar days, indicating to the supplier community that a goods, services or construction contract will be awarded to a pre-identified contractor. If no other supplier submits, on or before the closing date, a Statement of Capabilities that meets the minimum requirements identified in the ACAN, the Contracting Authority may then proceed to award a contract to the pre-identified contractor.
2. Rights of Suppliers
Suppliers who consider themselves fully qualified and available to provide the services or goods described in this ACAN may submit a Statement of Capabilities demonstrating how they meet the advertised requirement. This Statement of Capabilities must be provided via e-mail only to the contact person identified in Section 12 of the Notice on or before the closing date and time of the Notice. If the Bidder can clearly demonstrate they possess the required capabilities, the requirement will be opened to electronic or traditional bidding processes.
3. Proposed Contractor
Radha Jetty, Ottawa, Ontario
Julia Bareham, Saskatoon, Saskatchewan
4. Definition of Requirements or Expected Results
As part of DTAC, Committee members will be required to be active participants in discussions leading to the provision of recommendations to the NIHB Program which lead to a cost-effective drug formulary and improved prescribing, dispensing and use of drugs among First Nations and Inuit clients. Recommendations may be required regarding the following:
a. Clarification of Common Drug Review (CDR) and/or pan-Canadian Oncology Drug Review (pCODR) recommendations when required as well as offer additional expert review due to the specific needs of First Nations and Inuit clients.
b. Review of drugs or drug classes not reviewed by CDR or not under the mandate of the CDR Process. In this case, the Committee can provide one of the following recommendations:
i. List (open benefit)
ii. List with Criteria
iii. Do Not List (Exception – requests reviewed case by case)
iv. Exclusion (Drug not covered under any circumstances)
c. Review of individual requests by the NIHB Program for a drug or drug class review of existing NIHB DBL drug listing(s).
d. Maintenance and improvement of the centralized NIHB drug utilization evaluation (DUE) Program with recommendations and interventions being implemented at the national and regional level.
e. Establishment and review of criteria for retrospective national DUE and set out the terms for a specified number of retrospective DUE analyses.
f. Recommendation and monitoring of approved DUE projects, as required.
g. Recommendation of national policies, systems and procedures for retrospective DUE activities.
h. Provision of specific recommendations based on the DUE analyses reviewed by the Committee.
5. Minimum Requirements
Any interested supplier must demonstrate by way of a Statement of Capabilities that it meets the following minimum requirements:
To be considered as a member of the DTAC the candidate must hold a qualification and licensure in Canada as a physician, pharmacist, registered nurse or other professional with expertise in one or more areas such as, but not limited to:
a. drug use evaluation/utilization
b. critical appraisal
c. clinical epidemiology
d. medical or pharmacy quality assurance
e. aboriginal health issues
f. health systems research
g. medical or pharmacy education with First Nations expertise
h. pharmacoeconomics
i. general practice
j. internal medicine
k. hospital or community pharmacy
l. ethics
m. geriatrics
n. pediatrics
o. drug addiction treatment or prevention
6. Reason for Non-Competitive Award
Part 1, Section 6 (c) The nature of the work is such that it would not be in the public interest to solicit bids.
7. Applicable trade Agreements and Justification for Limited Tendering or the Procurement Strategy for Aboriginal Business
This procurement is subject to the following:
- Canadian Free Trade Agreement, (CFTA), Article 508
- North American Free Trade Agreement (NAFTA), Article 1011
- World Trade Organization (WTO), Article VIII
8. Ownership of Intellectual Property
If any, the Intellectual Property will be owned by the contractor.
9. Period of the Proposed Contract
The services of the Contractor will be required for a period of 2 years, with 3 additional option years, commencing upon awarding of the sole-sourced contract. The expected completion date of this contract is Nov 6, 2020.
10. Estimated Value of the Proposed Contract
The total estimated value of all two (2) resulting contracts including all option periods shall not exceed $137,500.00 including travel and living expenses (if applicable), and all applicable taxes.
11. Closing Date and Time
The Closing Date and Time for accepting Statements of Capabilities is November 2, 2018, 2 p.m. Central Daylight Time (CDT).
12. Contact Person
All enquiries must be addressed by e-mail to:
Name: Sandra Chrapun
E-Mail: s••••••••@••••••.ca
